Artificial intelligence (AI) involves developing ‘intelligent machines’ that can replicate, and occasionally surpass, human intelligence. The progress in AI systems and models represents one of the most remarkable technological advancements in recent years. In the life sciences sector, AI has notably accelerated drug discovery and enhanced patient care, with its impact anticipated to expand even more in the future.
Artificial intelligence (AI) has rapidly transformed numerous industries; the life sciences sector is no exception. Integrating AI into medicine and biology has empowered scientists to harness vast amounts of data, make precise predictions, and tackle complex medical challenges.
According to a report by BCC Research, the global AI market in life sciences is projected to grow from $9.8 billion in 2024 to $33.5 billion by 2029, with a compound annual growth rate (CAGR) of 27.9% during this period. This surge is driven by the increasing adoption of AI in drug discovery, disease diagnosis, and personalized healthcare, highlighting its potential to accelerate scientific research and enhance clinical trials.